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Abstract
Immunoinformatics is a science that helps to create significant immunological information using bioinformatics softwares and 
applications. One of the most important applications of immunoinformatics is the prediction of a variety of specific epitopes 
for B cell recognition and T cell through MHC class I and II molecules. This method reduces costs and time compared to 
laboratory tests. In this state-of-the-art review, we review about 50 papers to find the latest and most used immunoinformatic 
tools as well as their applications for predicting the viral, bacterial and tumoral structural and linear epitopes of B and T 
cells. In the clinic, the main application of prediction of epitopes is for designing peptide-based vaccines. Peptide-based 
vaccines are a considerably potential alternative to low-cost vaccines that may reduce the risks related to the production of 
common vaccines.
Keywords Epitope prediction · Immunoinformatics approach · Epitopes · Antigenic peptide · Vaccine design · Peptide-
based vaccines
Abbreviations
MHC  The major histocompatibility complex
HLA  The human leukocyte antigen
NMR  Nuclear magnetic resonance
IEDB  The immune epitope database
SVMHC  Server for prediction of MHC-binding peptides
MAPPP  MHC-I antigenic peptide processing prediction
EPSVR  Epitopes prediction with support vector 
regression
Introduction
The immune system consists of a complex network of thou-
sands of molecules that are interconnected. Application of 
high-throughput techniques can provide much invaluable 
information about the immune system and immune com-
ponent interactions. Therefore, there is a need for a com-
putational approach to store and analyze this information. 
Immunology has recently been influenced by resources and 
software providing insight into the features of the immune 
system and developed a new approach called immunoin-
formatics (Brusic and Petrovsky 2005; Gardy et al. 2009; 
Tomar and De 2010).
Immunoinformatics includes studies and design of algo-
rithms for potential mapping of B cell and T-cell epitopes. 
With the help of this knowledge, antigenic regions of the 
target proteins can be detected (Davies and Flower 2007). 
The research conducted on the basis of in silico immunoin-
formatics methods demonstrating the high potential of this 
approach in reducing the time and cost of immunogenicity 
studies and the reliable results of these methods in the past 
decade has attracted researchers to this approach. Antigenic 
regions called epitopes are regions of antigens that are iden-
tified by the immune system cells and have the immunogenic 
property for the immune cells (Chen et al. 2012).
B and T cells are the main components of the acquired 
immune system that bind to the antigen epitopes. In order to 
the T cells identify the antigens, antigenic peptides should 
be attached to clefts of MHC (major histocompatibility 
complex) molecules, also known as HLA (human leukocyte 
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antigen) in humans. MHC molecules expressed on antigen 
presenting cells (APCs) represent epitope peptides to T cells. 
These peptide epitopes should be linear that can attach to 
the cleft of MHCs. T cells are phenotypically classified into 
CD8+ and CD4+ lymphocytes. (Martin et al. 2006) Acti-
vated  CD8+ cells are called cytotoxic T cells (CTLs) bound 
to peptides presented by class I MHC molecules on APCs 
and are specific to intracellular antigens. Activated CD4+ 
cells are called T helper (TH) cells bound to peptides pre-
sented by class II MHC molecules and are specific to extra-
cellular antigens (Raoufi et al. 2015; Moise and De Groot 
2006). HLA system coded with 21 genes on chromosome 6 
is highly polymorphic. HLA Class I has three HLA-A, HLA-
B, and HLA-C loci, which detect peptide sequences of 8–12 
amino acids long. HLA Class II contains HLA-DR, HLA-DP 
and HLA-DQ, and is bound to larger sequences of 15–24 
amino acids. Identifying different alleles of HLAs is very 
important for predicting T cell epitopes (Sette et al. 1990).
Epitopes for B cells can be discontinuous (conforma-
tional) and/or continuous (linear). In linear epitopes, the 
amino acid sequence of the protein is used as an epitope and 
there are various criteria to choose an optimal epitope. The 
three-dimensional antigen structure plays an important role, 
and for predicting these epitopes, their three-dimensional 
structure should be used. Therefore, the peptide sequences 
of these epitopes can be adjacent to each other in the three-
dimensional structure, but in the linear sequence, they are 
distant from each other (Sharon et al. 2014). Nuclear mag-
netic resonance (NMR) and X-ray crystallographic methods 
are two methods for determining the number of epitopes 
for B cells that are very costly and time-consuming. Today, 
with the advancement of immunoinformatics tools, it is pos-
sible to predict B cell epitopes more accurately. The most 
antigenic epitopes are not linear sequences of amino acids; 
they are structures composed of different protein sections 
in the form of three-dimensional structure. Therefore, their 
bioinformatics modelling is required for the proper devel-
opment of antigenic regions in predicting the epitopes of B 
cells (Potocnakova et al. 2016).
Identification and prediction of antigenic regions for 
epitopes of T and B cells are the most important applications 
of immunoinformatics. Immunoinformatics appears to be a 
useful tool for the identification of new antigenic epitopes 
that can be used in new vaccine design for various infectious 
diseases caused by different pathogens including bacteria, 
viruses, fungi, and parasites. In addition to the microbial 
vaccine, immunoinformatics can be used for different types 
of malignancies with the pathogenic origin (i.e. hepatocellu-
lar carcinoma, cervical carcinoma, head and neck carcinoma, 
etc.) and non-pathogen based cancers including lung can-
cer, breast cancer, prostate cancer colon cancer etc. In this 
review, the major immunoinformatics software tools used 
in recent years are reviewed for introducing discontinuous 
and continuous viral, bacterial and tumor-specific epitopes 
for B and T cells based on their frequency in applied and 
valid results.
Schematic diagram of the stages of the peptide-based 
vaccine development, and an overview of the process of 
epitope mapping for peptide-based vaccine design against 
three types of viral, bacterial and tumor-specific antigens 
have been shown in Fig. 1.
Methodology
We conducted a state-of-the-art review aimed to study and 
evaluate the latest software and their applications for epitope 
mapping used in the recent publisher. Google Scholar and 
Scopus databases were used for searching. All papers match-
ing the immunogenicity search strategy in silico prediction 
and epitope prediction approaches and immunoinformatics 
tools were collected. Among these papers, 50 papers cov-
ering the years 2006 through 2018 were used as sources 
of this review. These papers have been fully studied and 
categorized. The classification was based on the softwares 
and applications to predict epitopes of MHC Class 1 and 
MHC class 2 for T cells as well as linear and conforma-
tional B cell epitopes. Also, the classification of the papers 
and their results based on the nature of the target antigen 
were divided into three sections: bacterial, viral and tumor-
specific antigens.
Finally, the quality of the results of the reviewed papers 
was evaluated, and the frequency of the application of each 
software in the specific sections was determined and dis-
cussed in separate sections of this study.
Prediction of T Cell Epitopes
Prediction of MHC‑I‑Binding Epitopes
Various bioinformatics tools are available to predict MHC-I 
epitopes. Among the papers reviewed, 37 cases have studied 
these epitopes; and the tools used in these studies are as 
follows:
IEDB, NetCTL, MHCPred, NetMHC, nHLAPred, CTL-
Pred, SVMHC, RANKPEP, BIMAS, MAPPP, ProPred, 
SYFPEITHI, PREDEP, MHCPEP.
The result of qualitative evaluations and frequency of 
software application in the papers confirms the frequent 
application of IEDB, but it is noteworthy that in many stud-
ies, first, using one of the tools listed above, epitopes are 
predicted, and then IEDB tool is used to verify and ensure 
the result. Of course, IEDB can also be used alone for pre-
dictions using Stabilized Matrix Method (SMM) method.
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The results of our studies for the frequency of each soft-
ware in the prediction of MHC-I bound epitopes by the 
nature of the antigen in three sections of viral, bacterial 
and tumor-specific antigens have been shown in Tables 1, 
2 and 3. As shown in Tables 1, 2 and 3, NetCTL and IEDB 
softwares were mostly used for the prediction of MHC-I 
bound viral epitopes, SVMHC software for the prediction 
of bacterial epitopes bound to the MHC-I and ProPred-I, 
SVMHC and SYFPEITHI softwares for the prediction of 
MHC-I bound tumor-specific epitopes.
Prediction of MHC‑II‑Binding Epitopes
According to quantitative investigations in this study, 
approximately 50% of the papers have been devoted to pre-
dicting MHC-II epitopes, frequently studying viruses.
Fig. 1  Schematic diagram of 
the stages of peptide-based 
vaccine development using 
immunoinformatics. At the first 
stage, candidate antigens are 
selected. These antigens can 
be viral, bacterial or tumor-
specific antigens. At the next 
stage (with in silico approach), 
immunoinformatics software 
and tools are used to find the 
epitopes of MHC I, MHC II and 
B cells. At this stage, in order 
to evaluate the top-level epitope 
connection to the favourable 
binding site, molecular dynam-
ics, molecular docking studies 
are used. Finally, high binding 
affinity epitopes for MHCs and 
B-cells are presented as pre-
dicted epitopes for the design of 
peptide-based vaccines
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Each of the papers used a series of bioinformatics tools 
to predict MHC-II epitopes, where the most widely used 
list in this study is as follows:
IEDB, NetMHC-II, MHCpred-II, MetaMHC-II, MetaS-
VMP, Propred-II, RANKPEP, PREDIVAC, SYFPEITH, 
BIMAS, CTL-Pred, EpiTOP, MHCPEP, EpiVax, PRE-
DEPP, TEPITOPE, EPIPREDICT, EpiDOCK, Concensus, 
and EpiMatrix.
The qualitative studies and frequency of software appli-
cation in these studies have shown that IEDB is among the 
most widely used and most available tools.
As shown in Table 1, 2 and 3, the results of our stud-
ies revealed the frequency of each software in the pre-
diction of MHC-II attached epitopes according to the 
nature of antigens evaluated in the three sections of viral, 
bacterial and tumor-specific antigens. According to these 
Tables, IEDB software was mostly used for the predic-
tion of MHC-II attached virus-based epitopes, Propred-II 
software for the prediction of MHC-II attached bacterial 
epitopes and MHCpred software for the prediction of 
MHC-II attached tumor-specific epitopes.
Prediction of B Cell Epitopes
Prediction of B Cell Linear Epitopes
Prediction of linear epitopes testing due to the continuity 
of amino acids unlike conformational epitopes had fewer 
complexities and problems. Therefore, 58% of the papers 
reviewed had addressed these epitopes.
According to studied papers, bioinformatics tools to 
predict linear epitopes are as follows:
Bepipred, BCpred, ABCpred, Pcipep, BCEpred, 
BepiTope, PrediTop, PEOPLE, LBtope, SVMTrip, COBE-
pro, EPMLR and Igpred.
Table 2  The assortment of articles for epitope prediction of bacterial antigens (8 articles out of 50 articles)
Their related web tools have been shown in the second column. In the third and fourth column, the frequency and percentage of the regularity of 
each web tool in articles are shown
a Six cases of 50 articles was studied for prediction of MHC Class I epitopes
b Five cases of 50 articles were studied for prediction of MHC Class II epitopes
c Five articles were studied on discontinuous B-cell epitope prediction
d Five articles were studied on continuous B-cell epitope prediction
Bacterial antigen
In silico softwares fi fi/N × 100
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The qualitative studies and frequency of using software 
programs in 29 papers showed that Bepipred has the most 
application for predicting epitopes.
The prediction of linear epitopes is not limited to using 
an informatics tool, but it requires the evaluation of side 
features of methods used simultaneously for this purpose, 
that includes:
Koloaskar-Tongankar antigenicity, Emini surface acces-
sibility prediction, Chou-fasman beta-turn prediction, 
prediction of floppy-prediction and Parker hydrophilicity 
prediction.
Tables 1, 2 and 3 show the results of our studies using 
software programs in the prediction of linear epitopes of 
B cell according to the nature of the antigens evaluated in 
the three sections of viral, bacterial, and tumor-specific 
antigens. Based on our review, Bepipred software had the 
highest frequency for predicting linear viral B cell epitopes 
and BCpred software for predicting linear bacterial B cell 
epitopes. Also, ABCpred software had the highest fre-
quency for predicting tumor-specific B cell epitopes.
Prediction of Conformational B Cell Epitopes
Among the 50 papers reviewed, 15 cases for conformational 
epitopes were found.
In previous studies, various bioinformatics tools have 
been introduced to assist in the process of prediction of dis-
continuous epitopes, each which has its own features and is 
selected depending on the type of work and purpose of the 
user as follows:
Discotope, Ellipro, CBTope, Epitope, BEPro, CEP, 
SEPPA, CED, EPITOME, MAPOTOPE, EPCES, EPSVR 
and EPMETA.
With qualitative reviews and frequency of applications in 
the previous studies conducted on the results of the papers, 
we found that among the software programs introduced, Dis-
cotope and Ellipro were the most widely utilized.
Tables 1, 2 and 3 show the results of our studies in the 
frequency of each software for prediction of conforma-
tional epitopes of B cell according to the nature of the 
antigen evaluated in the three sections of viral, bacterial 
Table 3  The assortment of articles for epitope prediction of bacterial antigens (4 articles out of 50 articles)
Their related web tools have been shown in the second column. In the third and fourth columns, the frequency and percentage of the regularity 
of each web tool in articles are shown
a Three cases of 50 articles were studied for prediction of MHC Class I epitopes
b Three cases of 50 articles were studied for prediction of MHC Class II epitopes
c Four articles were studied on discontinuous B-cell epitope prediction
d Three articles were studied on continuous B-cell epitope prediction
Tumor cell antigen
In silico softwares fi fi/N × 100
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and tumor-specific antigens. Based on our investigations, 
Discotope and Ellipro softwares are most widely used for 
predicting conformational viral B cell epitopes and Disco-
tope software is most widely used for predicting bacterial 
conformational B cell epitopes and predicting tumor-specific 
B cell epitopes.
Molecular Docking
Molecular docking is a method for predicting how differ-
ent formations of a small molecule or combination of mol-
ecules connected to a suitable target site. This prediction 
is performed through a computerized program, including 
regeneration of all possible formations of ligand structure 
and placement of all these ligand formations in a cavity of 
the active target protein position and then scoring of the 
examined conditions based on free energy or binding energy.
In the field of epitope mapping, after predicting and 
evaluating the candidate epitopes, the molecular docking 
approach allows us to study the predicted epitopes’ connec-
tion to the binding packet (cavity binding site) of the anti-
body molecules, MHC-I and MHC-II. Then evaluated in 
terms of the number of hydrogen bindings and free energy or 
binding energy with a strong binding potential for screening 
in silico candidate epitopes (Friesner et al. 2004).
Among the 50 papers studied, we reviewed 19 papers on 
docking.
The following are softwares and tools required for molec-
ular docking used in the previous studies:
Autodock Vina, autodock 4, Patch dock, Molegro Virtual 
Docker, Mti auto dock, Cluspro 2.0 and Python Prescription.
It has been shown that the most widely used of these soft-
ware programs in previous studies was Autodock including 
autodock vina and autodock 4.
Conclusions
Epitope identification using high-performance immuno-
analytic tools can be very useful in various applications 
in the field of epitope mapping, including the design of 
peptide-based vaccines, identification of immunological 
processes, prediction of epitopes used in the diagnosis of 
diseases, determination of features of antibodies in various 
diseases, etc. (Hemmati et al. 2017; Mohsenzadegan et al. 
2015, 2018).
The proper and accurate prediction of epitopes can be the 
basis for the development of therapeutic methods, includ-
ing the production and design of peptide-based vaccines. 
Peptide-based vaccines are one of the attractive and alterna-
tive strategies for the design of vaccines, which only contain 
peptide fragments with a length of 20–30 amino acids of 
the pathogen proteins that have the highest antigenicity and 
can stimulate and activate the immune response. In fact, the 
immune response is developed only against immunogenic 
epitopes, and additional portions of antigens causing allergic 
reactions that can be removed (Mohsenzadegan et al. 2018).
Therefore, a possible alternative method for immuniza-
tion is the identification of peptide epitopes that stimulate 
the immune responses and the use of their fully synthetic 
copies as a vaccine. These peptides are a good candidate 
for vaccine production, because they are easily produced, 
not mutated, are chemically stable and potentially do not 
cause infection. These sequences can be also manipulated. 
In this case, their chemical stability can be increased, and 
unwanted side effects seen in normal sequences can be 
minimized through these manipulations. The identification 
of peptide epitopes can be useful in the production of vac-
cines against microorganisms that have very little growth 
in the medium, as well as microorganisms whose antigenic 
regions are not detected during the normal infection of the 
immune system. These methods are used in the production 
of the vaccine against anti-cancer antigens (Mohsenzade-
gan et al. 2015; Perrie et al. 2007; Petrovsky and Aguilar 
2004; Thompson and Staats 2011; Li et al. 2014).
The advancement of next-generation sequencing (NGS) 
techniques that provide the complete and accurate sequences 
of genomes of pathogens, and even humans, contribute to 
the advancement of epitope predictive techniques as well as 
the facility of designing and developing peptide-based vac-
cines. These vaccines can be universal and work against all 
types of microorganisms strains as well as can be designed 
to work for all individuals, given the presence of different 
HLA alleles per person  (Toussaint et al. 2011; Backert and 
Kohlbacher 2015). In addition, B and T cell epitopes can be 
attached together and create an immunogen molecule. The 
use of immunoinformatics methods to predict epitopes and 
subsequent development of peptide-based vaccines reduces 
the costs and the time as well as increases accuracy com-
pared to pure laboratory tests (Raoufi et al. 2015).
As shown in Tables 1, 2, and 3, our investigations iden-
tified the frequency and application of each of the novel 
software used for epitope mapping. The results obtained 
will be very useful and valuable for future studies in 
research on epitope regions’ for viral, bacterial and tumor 
antigens. We hope that the relationship between research 
centers and companies producing immunoinformatics soft-
wares will be facilitated by scientists and researchers in 
this field in the near future.
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